US5641474A
(en)
*
|
1987-06-24 |
1997-06-24 |
Autoimmune, Inc. |
Prevention of autoimmune diseases by aerosol administration of autoantigens
|
US5645820A
(en)
*
|
1987-06-24 |
1997-07-08 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5571499A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5571500A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases through administration by inhalation of autoantigens
|
US5869054A
(en)
*
|
1987-06-24 |
1999-02-09 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of autoantigens
|
US6113903A
(en)
*
|
1989-03-21 |
2000-09-05 |
The Immune Response Corporation |
Peptides and methods against diabetes
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US5891435A
(en)
*
|
1993-04-16 |
1999-04-06 |
Research Corporation Technologies, Inc. |
Methods and compositions for delaying or preventing the onset of autoimmune disease
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
GB9319429D0
(en)
*
|
1993-09-21 |
1993-11-03 |
London Health Ass |
Methods and products for controlling immune responses in mammals
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
CN1088580C
(zh)
|
1994-12-22 |
2002-08-07 |
阿斯特拉公司 |
气溶胶药物制剂
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
EP0806945B1
(en)
*
|
1994-12-22 |
2003-04-23 |
AstraZeneca AB |
Therapeutic preparation for inhalation containing parathyro d hormone, pth
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
WO1997002043A1
(en)
*
|
1995-06-30 |
1997-01-23 |
Novo Nordisk A/S |
Prevention of a disease having the characteristics of diabetes
|
US6488933B2
(en)
|
1995-07-05 |
2002-12-03 |
Yeda Research And Development Co. Ltd. |
Preparations for the treatment of T cell mediated diseases
|
US5856446A
(en)
*
|
1995-07-07 |
1999-01-05 |
Autoimmune Inc. |
Method of treating rheumatoid arthritis with low dose type II collagen
|
WO1997009061A1
(en)
*
|
1995-09-06 |
1997-03-13 |
Alexion Pharmaceuticals, Inc. |
Treatment of diabetes via administration of hormonally ineffective insulin
|
SE520392C2
(sv)
*
|
1996-09-27 |
2003-07-01 |
Creative Peptides Sweden Ab C |
Specifika peptider för behandling av diabetes mellitus
|
US20050025758A1
(en)
*
|
1996-10-01 |
2005-02-03 |
Harrison Leonard Charles |
Method and compositions for treatment of insulin-dependant diabetes mellitus
|
EP2301567A1
(en)
*
|
1997-02-28 |
2011-03-30 |
Enzo Therapeutics, Inc. |
Selective immune down regulation (SIDR) for transplantation
|
US5948407A
(en)
*
|
1997-03-19 |
1999-09-07 |
Shire Laboratories Inc. |
Oral induction of tolerance to parenterally administered non-autologous polypeptides
|
DE19733651A1
(de)
*
|
1997-08-04 |
1999-02-18 |
Boehringer Ingelheim Pharma |
Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
|
US20060239930A1
(en)
*
|
1997-08-04 |
2006-10-26 |
Herbert Lamche |
Process for nebulizing aqueous compositions containing highly concentrated insulin
|
US6068844A
(en)
*
|
1997-12-19 |
2000-05-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
US20040062802A1
(en)
*
|
1998-04-02 |
2004-04-01 |
Hermelin Victor M. |
Maximizing effectiveness of substances used to improve health and well being
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6417208B1
(en)
*
|
1999-02-05 |
2002-07-09 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of identification of inhibitors of PDE1C
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CA2274414A1
(en)
*
|
1999-06-11 |
2000-12-11 |
Universite Laval |
Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
AU779986B2
(en)
*
|
1999-06-29 |
2005-02-24 |
Mannkind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
US7166280B2
(en)
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US6543682B1
(en)
|
2000-05-03 |
2003-04-08 |
Nichole Glaser |
Insulin-dose calculator disk
|
DE60129550T2
(de)
*
|
2000-05-12 |
2008-04-10 |
The Government Of The United States Of America, As Represented By The Department |
Verwendung von niedrigen dosen estrogen in kombination mit immunotherapeutischen verbindungen zur behandlung von immunkrankheiten
|
US7462486B2
(en)
*
|
2000-05-12 |
2008-12-09 |
Oregon Health & Science University |
Methods of selecting T cell receptor V peptides for therapeutic use
|
EP1286686B1
(en)
|
2000-05-24 |
2007-07-25 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES |
E-selectin for treating or preventing stroke
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
IL158192A0
(en)
*
|
2001-05-04 |
2004-03-28 |
Pfizer Prod Inc |
Method of preventing type 2 diabetes with aerosolized insulin
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US20030198666A1
(en)
*
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
ES2300568T3
(es)
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
AU2004233693B2
(en)
*
|
2003-04-28 |
2007-07-19 |
Funahashi, Toru |
Adiponectin production enhancer
|
EP1618893A4
(en)
*
|
2003-04-28 |
2009-08-12 |
Sankyo Co |
MEANS FOR INCREASING SUGAR CAPACITY
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
JP2007517892A
(ja)
*
|
2004-01-12 |
2007-07-05 |
マンカインド コーポレイション |
2型糖尿病における血清プロインスリンレベルを低下させる方法
|
US7279457B2
(en)
|
2004-03-12 |
2007-10-09 |
Biodel, Inc. |
Rapid acting drug delivery compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
EP1768668A2
(en)
|
2004-06-16 |
2007-04-04 |
Tap Pharmaceutical Products, Inc. |
Multiple ppi dosage form
|
CA2910494C
(en)
|
2004-07-19 |
2018-10-23 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
WO2006012641A2
(en)
*
|
2004-07-30 |
2006-02-02 |
Oregon Health And Science University |
Methods for detecting and treating autoimmune disorders
|
MX2007001903A
(es)
|
2004-08-20 |
2007-08-02 |
Mannkind Corp |
Catalisis de sintesis de dicetopiperazina.
|
KR101306384B1
(ko)
|
2004-08-23 |
2013-09-09 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는디케토디옥산염
|
EP1874334A4
(en)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
|
JP5465878B2
(ja)
|
2005-09-14 |
2014-04-09 |
マンカインド コーポレイション |
活性薬剤に対する結晶性微粒子表面の親和性を増大させることに基づく薬物処方の方法
|
EP1931665A1
(en)
|
2005-09-20 |
2008-06-18 |
Schering Corporation |
1-[[1-[(2-amin0-6-methyl-4-pyridinyl)methyl]-4-flu0r0-4-piperidinyl,]carbonyl]-4-[2-(2-pyridinyl)-3h-imidaz0[4, 5-b]pyridin-3-yl]piperidine useful as histamine h3 antagonist
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
CN104383546B
(zh)
|
2006-02-22 |
2021-03-02 |
曼金德公司 |
用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
|
WO2007121256A2
(en)
*
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
PL2134351T3
(pl)
|
2007-03-13 |
2017-10-31 |
Jds Therapeutics Llc |
Sposoby i kompozycje do przedłużonego uwalniania chromu
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
CA2688161C
(en)
|
2007-06-04 |
2020-10-20 |
Kunwar Shailubhai |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
RU2013106514A
(ru)
|
2007-10-12 |
2015-03-10 |
Такеда Фармасьютикалз Норт Америка, Инк. |
Способы лечения нарушений желудочно-кишечного тракта независимо от потребления пищи
|
MX2010003979A
(es)
|
2007-10-16 |
2010-06-02 |
Biocon Ltd |
Composicion farmaceutica oralmente administrable y proceso para su preparacion.
|
AU2008317057B8
(en)
|
2007-10-22 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Bicyclic Heterocycle Derivatives and their use as modulators of the activity of GPR119
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
AU2009204309B2
(en)
*
|
2008-01-04 |
2012-11-22 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
CA2724426A1
(en)
|
2008-05-19 |
2009-11-26 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CN104689432B
(zh)
|
2008-06-13 |
2018-07-06 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
JP5479465B2
(ja)
|
2008-06-20 |
2014-04-23 |
マンカインド コーポレイション |
吸入努力をリアルタイムにプロファイルする対話式機器および方法
|
AU2009270971A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic Heterocycle Derivatives and use thereof as GPR119 modulators
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
WO2010027567A2
(en)
|
2008-07-23 |
2010-03-11 |
Schering Corporation |
Tricyclic spirocycle derivatives and methods of use thereof
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
EP2350020B1
(en)
|
2008-10-03 |
2014-08-13 |
Merck Sharp & Dohme Corp. |
Spiro-imidazolone derivatives as glucagon receptor antagonists
|
WO2010045306A2
(en)
|
2008-10-16 |
2010-04-22 |
Schering Corporation |
Azine derivatives and methods of use thereof
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
WO2010075068A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
WO2010071822A1
(en)
|
2008-12-19 |
2010-06-24 |
Schering Corporation |
Piperidine and piperazine derivatives and methods of use thereof
|
EP2379564A1
(en)
|
2008-12-19 |
2011-10-26 |
Schering Corporation |
Bicyclic heterocyclic derivatives and methods of use thereof
|
EP2382203B1
(en)
|
2008-12-23 |
2015-01-14 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and methods of use thereof
|
JP2012513469A
(ja)
|
2008-12-23 |
2012-06-14 |
シェーリング コーポレイション |
ピリミジン誘導体及びその使用法
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
SG173112A1
(en)
*
|
2009-01-28 |
2011-08-29 |
Smartcells Inc |
Conjugate based systems for controlled drug delivery
|
EP2397152B1
(en)
|
2009-02-12 |
2014-05-28 |
Proyecto de Biomedicina Cima, S.L. |
Use of cardiotrophin- 1 for the treatment of metabolic diseases
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
AR075858A1
(es)
|
2009-03-18 |
2011-05-04 |
Schering Corp |
Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa
|
US10011906B2
(en)
|
2009-03-31 |
2018-07-03 |
Beohringer Ingelheim International Gmbh |
Method for coating a surface of a component
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
EP2414348B1
(en)
|
2009-04-03 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
EP2440553B1
(en)
|
2009-06-12 |
2017-08-23 |
Merck Sharp & Dohme Corp. |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
|
EP2440184B1
(en)
|
2009-06-12 |
2023-04-05 |
MannKind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
US20120172369A1
(en)
|
2009-09-14 |
2012-07-05 |
Ting Pauline C |
Inhibitors of diacylglycerol acyltransferase
|
US8759357B2
(en)
|
2009-10-08 |
2014-06-24 |
Merck Sharp & Dohme Corp. |
Inhibitors of fatty acid binding protein (FABP)
|
AU2010313469A1
(en)
|
2009-10-29 |
2012-06-07 |
Merck Sharp & Dohme Corp. |
Bridged Bicyclic Piperidine Derivatives and methods of use thereof
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
WO2011062889A1
(en)
|
2009-11-23 |
2011-05-26 |
Schering Corporation |
Pyrimidine ether derivatives and methods of use thereof
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
EP2503887B1
(en)
|
2009-11-24 |
2016-01-06 |
Merck Sharp & Dohme Corp. |
Substituted biaryl derivatives and methods of use thereof
|
UA107097C2
(en)
|
2009-11-25 |
2014-11-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Dispenser
|
WO2011064163A1
(en)
|
2009-11-25 |
2011-06-03 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
EP2585151B1
(en)
|
2010-06-24 |
2018-04-04 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
CA2806399A1
(en)
|
2010-07-28 |
2012-02-02 |
Smartcells, Inc. |
Recombinantly expressed insulin polypeptides and uses thereof
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US8603527B2
(en)
*
|
2010-10-25 |
2013-12-10 |
Signal Pharmaceuticals, Llc |
Pharmaceutical formulations of a substituted diaminopurine
|
JP6152346B2
(ja)
|
2011-03-01 |
2017-06-21 |
ジェーディーエス セラピューティックス、エルエルシーJDS Therapeutics,LLC |
糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物
|
WO2012130757A1
(de)
|
2011-04-01 |
2012-10-04 |
Boehringer Ingelheim International Gmbh |
Medizinisches gerät mit behälter
|
DK2694402T3
(en)
|
2011-04-01 |
2017-07-03 |
Mannkind Corp |
BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
AU2012328885B2
(en)
|
2011-10-24 |
2017-08-31 |
Mannkind Corporation |
Methods and compositions for treating pain
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
AU2013289957B2
(en)
|
2012-07-12 |
2017-02-23 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014057522A1
(en)
|
2012-10-12 |
2014-04-17 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
US10441560B2
(en)
|
2013-03-15 |
2019-10-15 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
EP2968245B1
(en)
|
2013-03-15 |
2021-05-05 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
US9486494B2
(en)
|
2013-03-15 |
2016-11-08 |
Synergy Pharmaceuticals, Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
EP3587404B1
(en)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
JP6606491B2
(ja)
|
2013-06-05 |
2019-11-13 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
|
BR112016000937A8
(pt)
|
2013-07-18 |
2021-06-22 |
Mannkind Corp |
formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
ES2836977T3
(es)
|
2013-08-09 |
2021-06-28 |
Boehringer Ingelheim Int |
Nebulizador
|
WO2015018904A1
(en)
|
2013-08-09 |
2015-02-12 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2015051052A2
(en)
|
2013-10-04 |
2015-04-09 |
Merck Sharp & Dohme Corp. |
Glucose-responsive insulin conjugates
|
US10195374B2
(en)
|
2014-05-07 |
2019-02-05 |
Boehringer Ingelheim International Gmbh |
Container, nebulizer and use
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
WO2015169430A1
(en)
|
2014-05-07 |
2015-11-12 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
KR102492824B1
(ko)
|
2014-05-07 |
2023-01-30 |
베링거 인겔하임 인터내셔날 게엠베하 |
분무기, 표시 디바이스 및 컨테이너
|
HUE049261T2
(hu)
|
2014-07-15 |
2020-09-28 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
CD44 izolált polipeptidek és alkalmazásaik
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
TW201629063A
(zh)
|
2014-10-06 |
2016-08-16 |
標誌製藥公司 |
經取代胺基嘌呤化合物、其組合物及用其之治療方法
|
CA2936741C
(en)
|
2014-10-31 |
2018-11-06 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
MX2018009748A
(es)
|
2016-02-11 |
2019-02-07 |
Nutrition 21 Llc |
Composiciones que contienen cromo para mejorar la salud y el estado físico.
|
CN109069512B
(zh)
|
2016-04-01 |
2022-06-14 |
西格诺药品有限公司 |
取代的氨基嘌呤化合物、其组合物以及相关治疗方法
|
DK3436019T3
(da)
|
2016-04-01 |
2021-10-11 |
Signal Pharm Llc |
(1s,4s)-4-(2-(((3s,4r)-3-fluortetrahydro-2h-pyran-4-yl)amino)-8-((2,4,6-trichlorphenyl)amino)-9h-purin-9-yl)-1-methylcyclohexan-1-carboxamid og fremgangsmåder til anvendelse deraf
|
KR20200061363A
(ko)
|
2017-10-04 |
2020-06-02 |
셀진 코포레이션 |
시스-4-[2-{[(3s,4r)-3-플루오로옥산-4-일]아미노}-8-(2,4,6-트리클로로아닐리노)-9h-퓨린-9-일]-1-메틸사이클로헥산-1-카르복스아미드의 제조 공정
|
AU2018345647A1
(en)
|
2017-10-04 |
2020-04-16 |
Celgene Corporation |
Compositions and methods of use of cis-4-(2-{((3S,4R)-3-fluorooxan-4-yl) amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2023200363A1
(ru)
*
|
2022-04-13 |
2023-10-19 |
Фания Иршатовна МАГАНОВА |
Способ получения пероральной формы субстанции, содержащей инсулин
|